These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 28472014)
1. Protection by the Eph-Ephrin System Against Mesenteric Ischemia-Reperfusion Injury. Vivo V; Zini I; Cantoni AM; Grandi A; Tognolini M; Castelli R; Ballabeni V; Bertoni S; Barocelli E Shock; 2017 Dec; 48(6):681-689. PubMed ID: 28472014 [TBL] [Abstract][Full Text] [Related]
2. UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling. Giorgio C; Allodi M; Palese S; Grandi A; Tognolini M; Castelli R; Lodola A; Flammini L; Cantoni AM; Barocelli E; Bertoni S Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34074058 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases. Baldwin C; Chen ZW; Bedirian A; Yokota N; Nasr SH; Rabb H; Lemay S Am J Physiol Renal Physiol; 2006 Nov; 291(5):F960-71. PubMed ID: 16735461 [TBL] [Abstract][Full Text] [Related]
5. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness. Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE Biochem Biophys Res Commun; 2004 Aug; 320(4):1096-102. PubMed ID: 15249202 [TBL] [Abstract][Full Text] [Related]
6. EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice. Whitehurst KS; Chan VA; Estes HK; Valsaraj S; Kent S; Sharma UM; Chase RC; Bhuiyan M; Virag JAI Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823610 [TBL] [Abstract][Full Text] [Related]
7. Eph/ephrin signalling serves a bidirectional role in lipopolysaccharide‑induced intestinal injury. Xiong Y; Li KX; Wei H; Jiao L; Yu SY; Zeng L Mol Med Rep; 2018 Aug; 18(2):2171-2181. PubMed ID: 29901151 [TBL] [Abstract][Full Text] [Related]
8. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer. Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975 [TBL] [Abstract][Full Text] [Related]
9. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation. Yang XY; Zhu WJ; Jiang H Mol Cell Biochem; 2012 Feb; 361(1-2):259-65. PubMed ID: 22009484 [TBL] [Abstract][Full Text] [Related]
10. Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury. Carpenter TC; Schroeder W; Stenmark KR; Schmidt EP Am J Respir Cell Mol Biol; 2012 Jan; 46(1):40-7. PubMed ID: 21799118 [TBL] [Abstract][Full Text] [Related]
11. Ephrin-A1-mediated dopaminergic neurogenesis and angiogenesis in a rat model of Parkinson's disease. Jing X; Miwa H; Sawada T; Nakanishi I; Kondo T; Miyajima M; Sakaguchi K PLoS One; 2012; 7(2):e32019. PubMed ID: 22363788 [TBL] [Abstract][Full Text] [Related]
12. Bifunctional role of ephrin A1-Eph system in stimulating cell proliferation and protecting cells from cell death through the attenuation of ER stress and inflammatory responses in bovine mammary epithelial cells. Kang M; Jeong W; Bae H; Lim W; Bazer FW; Song G J Cell Physiol; 2018 Mar; 233(3):2560-2571. PubMed ID: 28777434 [TBL] [Abstract][Full Text] [Related]
13. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase. Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury. Kim A; Seong KM; Choi YY; Shim S; Park S; Lee SS Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33265912 [TBL] [Abstract][Full Text] [Related]